Evaluation of response rate and disease control rate as potential predictors of overall survival in anthracycline-pretreated women receiving first-line chemotherapy for metastatic breast cancer (MBC).
J. Liu
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
K. S. Albain
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly
S. Chan
Research Funding - Lilly
A. D. Seidman
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly
D. Tai
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Y. Wang
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
L. Zhao
Employment or Leadership Position - Lilly
Stock Ownership - Lilly